|Articles|June 1, 2019
- BioPharm International-06-01-2019
- Volume 43
- Issue 6
BioPharm International, June 2019 Issue (PDF)
Click the title above to open the BioPharm International June 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 6 years ago
FDA Advances New Approach to Drug Quality Assessmentover 6 years ago
Bio/Pharma Facilities Still Have a Lot to Learnover 6 years ago
Moving PAT from Concept to Realityover 6 years ago
Streamlining Upstream Processing: A Good Place to Startover 6 years ago
On the Right Trackover 6 years ago
Quality Agreements and Out-of-Specification Investigationsover 6 years ago
Addressing the Complex Nature of Downstream Processing with QbDover 6 years ago
From Data to InformationNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
